Form 4: Edgewell Director Gary Waring Receives Stock Equivalents

Sentiment:

Insider Transaction Report


Edgewell Personal Care Director Gary Waring was granted 7,817 restricted stock equivalents, convertible into common stock.

Summary

  • Gary Waring, a Director of Edgewell Personal Care Co (EPC), acquired 7,817 Restricted Stock Equivalents.
  • The transaction occurred on February 5, 2026.
  • These restricted stock equivalents convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders.
  • Conversion can be deferred until the termination of service on Edgewell's Board of Directors.
  • The acquisition price was $0, indicating a grant as part of compensation.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, as it signifies continued alignment of a director's interests with the company's long-term performance through equity compensation.

Positives

  • The grant of restricted stock equivalents aligns the director's interests with the long-term performance of the company and shareholder value.

Future Outlook

The Restricted Stock Equivalents are set to convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders, or can be deferred until the termination of service on the Board, indicating future equity ownership for the director.

Industry Context

StockSavvy.ai notes that equity grants to directors are a common practice across various industries, serving to align the interests of board members with those of shareholders and incentivize long-term commitment and performance.

Comparison to Industry Standards

  • Equity grants to directors, such as restricted stock equivalents, are a standard component of compensation packages in publicly traded companies across most sectors, including consumer goods, to foster alignment with shareholder interests. No specific comparable companies or projects are detailed in the filing.

Related Party Transactions

  • Grant of 7,817 restricted stock equivalents to Director Gary Waring as part of his compensation.

Stakeholder Impact

  • Shareholders: The grant enhances alignment between the director's financial interests and the company's performance, potentially leading to more shareholder-centric decision-making.
  • Director (Gary Waring): Receives equity compensation, increasing his direct stake and potential future wealth tied to the company's stock performance.

Next Steps

  • Conversion of Restricted Stock Equivalents into common stock on the day preceding the next annual meeting of shareholders.
  • Potential deferral of conversion until termination of service on Edgewell's Board of Directors.

Key Dates

DateDescription
02/05/2026Date of transaction for the acquisition of Restricted Stock Equivalents.
02/06/2026Signature date of the reporting person, LaTanya Langley.

Recommendation

hold

This Form 4 reports a routine equity grant to a director, which is a standard compensation practice and does not indicate a significant change in the company's fundamental outlook or operations. It reinforces director alignment but does not provide new information warranting a change in investment stance.

Keywords

Edgewell Personal Care, EPC, Gary Waring, Form 4, insider transaction, restricted stock equivalents, equity grant, director compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.